The Food and Drug Administration (FDA) has unexpectedly withdrawn its request for White House permission to conduct a study on the risks associated with kratom and psychedelics. As Marijuana Moment reported, this move comes in response to growing public criticism, particularly from advocates who have accused the agency of displaying a consistent bias against harm reduction strategies. Kratom Use in the U.S.Kratom is a tropical tree (Mitragyna Speciosa) native to Southeast Asia with opiate-like properties. Although the FDA has not approved any use of kratom, it is often used to self-treat condi…